Literature DB >> 23219743

The Ala16Val MnSOD gene polymorphism modulates oxidative response to exercise.

Guilherme Bresciani1, Javier González-Gallego, Ivana B da Cruz, Jose A de Paz, María J Cuevas.   

Abstract

OBJECTIVES: In humans, the manganese-superoxide dismutase (MnSOD) gene contains a polymorphism (Ala16Val) that has been related to several metabolic dysfunctions and chronic diseases. However, the obtained results suggest that risks related to this polymorphism are directly influenced by environmental factors. Because few studies have analyzed this possible influence, we performed a controlled study to evaluate if the oxidative stress caused by exercise is differentially modulated by the Ala16Val MnSOD polymorphism. DESIGN AND METHODS: Fifty-seven males were previously genotyped and 10 subjects per genotype were selected to perform a bout of controlled intense exercise. MnSOD mRNA expression, protein content, enzyme activity, and total glutathione and thiol content from peripheral blood mononuclear cells were evaluated before and 1h after a bout of intense exercise.
RESULTS: The AA genotype participants showed increased post-exercise MnSOD mRNA expression and enzyme activity compared to baseline values. Conversely, MnSOD mRNA expression did not change but protein thiol content decreased significantly after the bout of exercise in VV carriers. A comparison of the genotypes showed that the AA genotype presented a higher MnSOD protein content than VV volunteers after exercise; while a dose-effect for the A allele was found for enzyme activity.
CONCLUSION: This study supports recent evidence that genotypes of key antioxidant enzymes may be associated with differential oxidative stress modulation and the hypothesis that the risk of disease associated with the MnSOD Ala16Val gene polymorphism may be controlled by environmental factors.
Copyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23219743     DOI: 10.1016/j.clinbiochem.2012.11.020

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Genetic Variability of Inflammation and Oxidative Stress Genes Affects Onset, Progression of the Disease and Survival of Patients with Amyotrophic Lateral Sclerosis.

Authors:  Metka Ravnik-Glavač; Katja Goričar; David Vogrinc; Blaž Koritnik; Jakob Gašper Lavrenčič; Damjan Glavač; Vita Dolžan
Journal:  Genes (Basel)       Date:  2022-04-25       Impact factor: 4.141

2.  Increased SOD2 in the diaphragm contributes to exercise-induced protection against ventilator-induced diaphragm dysfunction.

Authors:  Aaron B Morton; Ashley J Smuder; Michael P Wiggs; Stephanie E Hall; Bumsoo Ahn; J Matthew Hinkley; Noriko Ichinoseki-Sekine; Andres Mor Huertas; Mustafa Ozdemir; Toshinori Yoshihara; Nicholas R Wawrzyniak; Scott K Powers
Journal:  Redox Biol       Date:  2018-10-21       Impact factor: 11.799

3.  Response of oxidative stress and inflammatory biomarkers to a 12-week aerobic exercise training in women with metabolic syndrome.

Authors:  Juliano Boufleur Farinha; Flávia Mariel Steckling; Sílvio Terra Stefanello; Manuela Sangoi Cardoso; Larissa Santos Nunes; Rômulo Pillon Barcelos; Thiago Duarte; Nélson Alexandre Kretzmann; Carlos Bolli Mota; Guilherme Bresciani; Rafael Noal Moresco; Marta Maria Medeiros Frescura Duarte; Daniela Lopes Dos Santos; Félix Alexandre Antunes Soares
Journal:  Sports Med Open       Date:  2015-04-08

4.  Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases the risk of depression and self-reported psychological stress in free-living elderly people.

Authors:  Ivo Emilio da Cruz Jung; Ivana Beatrice Mânica da Cruz; Fernanda Barbisan; Alexis Trott; Lucien J Houenou; Bárbara Osmarin Turra; Thiago Duarte; Raquel de Souza Praia; Ednea Aguiar Maia-Ribeiro; Jaqueline da Costa Escobar Piccoli; Claudia Giugliano Bica; Marta Maria Medeiros Frescura Duarte
Journal:  Mol Genet Genomic Med       Date:  2019-12-31       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.